NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Depression in the Elderly and Cerebral Amyloid Plaques: Characterization by [18F] AV-45 Affectives Symptoms and Amyloïd Plaques (ASAP)
Depression in the Elderly and Cerebral Amyloid Plaques: Characterization by [18F] AV-45 Affectives Symptoms and Amyloïd Plaques (ASAP)
CompletedNA
Sponsor: University Hospital, Tours
Conditions: Elderly, Major Depression
Interventions: 18FAV45
Countries: France
The primary objective of the study is to compare the brain amyloid load in fully, partially and non remitting depressed elderly patients at 8 weeks of antidepressant therapy, by using PET with \[F18\]AV45.
Eligibility overview
Sex: ALL
Age: 55 Years to —
Healthy volunteers: No
Study type: INTERVENTIONAL
Eligibility criteria
Inclusion Criteria * Adult 55 years or older * Native language : french * Study period \> 7 years * Major depression defined on the DSM-IV criteria assessed by MINI and HDRS score of 10 or over * Affiliation to the national health insurance system * Signed informed consent Exclusion Criteria * History of alcoholism or drug addiction * MMSE less than or equal to 17 * Major depression with psychotic features * Depressive episode resistant, patient who received two different antidepressants well conducted without significant therapeutic response * Any current or past episode of mania, schizophrenia or any other psychotic disorder * Any past history of stroke or Parkinson's disease * Any current significant unstable illness * Any past diagnosis of Alzheimer's disease * Any current treatment by AcethylCholinesterae inhibitor, memantine or antidepressant therapy. * Contraindications to MRI in patients with: 1. Metallic foreign body eye. 2. Any implanted electronic medical irremovably (pacemaker, neurostimulator, cochlear implants ...) 3. Metal heart valve, 4. Vascular clips formerly located on cranial aneurysm. * Contraindications to antidepressants * History of progressive disease that can affect the central nervous system such as uncontrolled diabetes, blood pressure greater than or equal to 180/100; chronic lung disease with hypoxia, head trauma with loss of consciousness greater than or equal to 15 minutes; brain surgery, encephalitis, recently treated cancer (\<1 year), altered cerebral metabolism including subjects with stroke sequelae extended. Patients with lacunar stroke without thalamic or striatal may be included.
Locations (10)
- Besançon, France
- Caen, France
- Lille, France
- Nice, France
- Paris, France
- Rennes, France
- Sotteville-lès-Rouen, France
- Strasbourg, France
- Toulouse, France
- Tours, France